http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2012176879-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56977 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 2012-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2012176879-A1 |
| titleOfInvention | Reagents and methods for cancer testing |
| abstract | Set of peptides consisting of peptides derived from tumor antigens that bind to HLA class I molecules, beads or ELISA plates to which peptides derived from tumor antigens that bind to HLA class I molecules are bound, peptides derived from tumor antigens that bind to HLA class I molecules For measurement of antibody titer against HLA, use of peptide derived from tumor antigen binding to HLA class I molecule for cancer diagnosis and prediction of prognosis of cancer patient using peptide derived from tumor antigen binding to HLA class I molecule Provide use. |
| priorityDate | 2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 252.